The botanical landscape of the mid-2020s continues to witness intense scientific inquiry into plant-derived compounds, with Mitragyna speciosa occupying a prominent position in contemporary pharmacological debates. Across an extensive international footprint spanning the United States, Canada, Brazil, Mexico, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, and Switzerland, researchers, clinicians, and regulatory authorities evaluate […]